Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth J Baum

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
JACC. Case Reports|October 23, 2023
Distinguishing Lysosomal Acid Lipase Deficiency From Familial HypercholesterolemiaSohum Sheth, Peter P Toth, Seth J Baum, et al.
Postgraduate Medicine|July 17, 2016
Focus on PCSK9 Inhibitors: From Genetics to Clinical PracticeMarc S Sabatine, James A Underberg, Michael Koren, et al.
Clinical Cardiology|March 26, 2018
The 2017 high blood pressure clinical practice guideline: The old and the newArthur Z Schwartzbard, Jonathan D Newman, Howard S Weintraub, et al.
Journal of Clinical Lipidology|December 16, 2014
The doctor's dilemma: challenges in the diagnosis and care of homozygous familial hypercholesterolemiaSeth J Baum, E J G Sijbrands, Pedro Mata, et al.
Circulation. Cardiovascular Quality and Outcomes|February 16, 2024
Trends in Patient Access to and Utilization of Prescribed PCSK9 Inhibitors in a Large US Claims Database From 2015 to 2021Diane E MacDougall, Seth J Baum, Catherine D Ahmed, et al.
Clinical Cardiology|March 23, 2017
PCSK9 inhibitor access barriers-issues and recommendations: Improving the access process for patients, clinicians and payersSeth J Baum, Peter P Toth, James A Underberg, et al.
Journal of Clinical Lipidology|May 5, 2026
A real-world study on the risk of acute pancreatitis and cardiovascular events among adults with severe or extreme hypertriglyceridemiaAsia Sikora Kessler, Kirti Batra, Qiana Amos, et al.
Lipids in Health and Disease|July 29, 2025
Rates of acute pancreatitis and cardiovascular events among adults with severe or extreme hypertriglyceridemia in US clinical practiceAsia Sikora Kessler, Seth J Baum, Emily Kutrieb, et al.
Journal of Clinical Lipidology|May 25, 2026
Comparative efficacy and safety of olezarsen vs plozasiran for familial chylomicronemia syndrome: A matching-adjusted indirect comparisonAsia Sikora Kessler, Paul Serafini, Divya Pushkarna, et al.
Lipids in Health and Disease|March 3, 2026
Correction: Rates of acute pancreatitis and cardiovascular events among adults with severe or extreme hypertriglyceridemia in US clinical practiceAsia Sikora Kessler, Seth J Baum, Emily Kutrieb, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
JACC. Case Reports|October 23, 2023
Distinguishing Lysosomal Acid Lipase Deficiency From Familial HypercholesterolemiaSohum Sheth, Peter P Toth, Seth J Baum, et al.
Postgraduate Medicine|July 17, 2016
Focus on PCSK9 Inhibitors: From Genetics to Clinical PracticeMarc S Sabatine, James A Underberg, Michael Koren, et al.
Clinical Cardiology|March 26, 2018
The 2017 high blood pressure clinical practice guideline: The old and the newArthur Z Schwartzbard, Jonathan D Newman, Howard S Weintraub, et al.
Journal of Clinical Lipidology|December 16, 2014
The doctor's dilemma: challenges in the diagnosis and care of homozygous familial hypercholesterolemiaSeth J Baum, E J G Sijbrands, Pedro Mata, et al.
Circulation. Cardiovascular Quality and Outcomes|February 16, 2024
Trends in Patient Access to and Utilization of Prescribed PCSK9 Inhibitors in a Large US Claims Database From 2015 to 2021Diane E MacDougall, Seth J Baum, Catherine D Ahmed, et al.
Clinical Cardiology|March 23, 2017
PCSK9 inhibitor access barriers-issues and recommendations: Improving the access process for patients, clinicians and payersSeth J Baum, Peter P Toth, James A Underberg, et al.
Journal of Clinical Lipidology|May 5, 2026
A real-world study on the risk of acute pancreatitis and cardiovascular events among adults with severe or extreme hypertriglyceridemiaAsia Sikora Kessler, Kirti Batra, Qiana Amos, et al.
Lipids in Health and Disease|July 29, 2025
Rates of acute pancreatitis and cardiovascular events among adults with severe or extreme hypertriglyceridemia in US clinical practiceAsia Sikora Kessler, Seth J Baum, Emily Kutrieb, et al.
Journal of Clinical Lipidology|May 25, 2026
Comparative efficacy and safety of olezarsen vs plozasiran for familial chylomicronemia syndrome: A matching-adjusted indirect comparisonAsia Sikora Kessler, Paul Serafini, Divya Pushkarna, et al.
Lipids in Health and Disease|March 3, 2026
Correction: Rates of acute pancreatitis and cardiovascular events among adults with severe or extreme hypertriglyceridemia in US clinical practiceAsia Sikora Kessler, Seth J Baum, Emily Kutrieb, et al.
Pageof 9